Knowledge-graph-enhanced multi-scale modeling for drug-drug interaction prediction

Drug-drug interaction (DDI) prediction is crucial for understanding combined medication effects and preventing adverse reactions. Traditional machine learning methods rely on handcrafted features and lack generalization, while existing deep learning approaches often fail to capture global and multi-scale drug relationships. To overcome these limitations, we propose ALG-DDI, a multi-scale feature fusion model that integrates three types of drug information: attribute (intrinsic drug structure), local correlations (with proteins and diseases), and global semantic information from the medical knowledge graph PrimeKG. We encode these using attribute masking, the idea of RGCN and GraphSAGE, and ComplEx, respectively. A transformer encoder with attention mechanism then fuses these multi-scale representations. The resulting drug pair vector is fed into a fully connected network for DDI prediction, which we also extend to DDI event prediction. Extensive evaluations on three datasets-including comparative experiments, cross-validation, retrospective analysis, and case studies-demonstrate that ALG-DDI outperforms existing state-of-the-art methods.

Authors

Institutions

Publication Details

Journal
Molecular Therapy — Nucleic Acids
Published
2026-02-04
DOI
https://doi.org/10.1016/j.omtn.2026.102855
Primary Topic
Advanced Graph Neural Networks
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Knowledge-graph-enhanced multi-scale modeling for drug-drug interaction prediction

Jiajie Peng, Qiang Deng, Peimeng Zhen, Jialu Hu et al.
Molecular Therapy — Nucleic Acids
Advanced Graph Neural Networks
article

Knowledge-graph-enhanced multi-scale modeling for drug-drug interaction prediction

Jiajie Peng, Qiang Deng, Peimeng Zhen, Jialu Hu, Xuequn Shang, Tao Wang, Yongtian Wang, Xu Zhang, Jing M. Chen, Zhuhong You
article en

Abstract

Drug-drug interaction (DDI) prediction is crucial for understanding combined medication effects and preventing adverse reactions. Traditional machine learning methods rely on handcrafted features and lack generalization, while existing deep learning approaches often fail to capture global and multi-scale drug relationships. To overcome these limitations, we propose ALG-DDI, a multi-scale feature fusion model that integrates three types of drug information: attribute (intrinsic drug structure), local correlations (with proteins and diseases), and global semantic information from the medical knowledge graph PrimeKG. We encode these using attribute masking, the idea of RGCN and GraphSAGE, and ComplEx, respectively. A transformer encoder with attention mechanism then fuses these multi-scale representations. The resulting drug pair vector is fed into a fully connected network for DDI prediction, which we also extend to DDI event prediction. Extensive evaluations on three datasets-including comparative experiments, cross-validation, retrospective analysis, and case studies-demonstrate that ALG-DDI outperforms existing state-of-the-art methods.

Molecular Therapy — Nucleic AcidsVol. 37(1)
Northwestern Polytechnical University (CN), Ningxia Medical University (CN), Xi'an University of Technology (CN), Ningxia Medical University General Hospital (CN), Ministry of Industry and Information Technology (CN)
Openalex Percentile: Top 70%
Advanced Graph Neural Networks
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Knowledge-graph-enhanced multi-scale modeling for drug-drug interaction prediction — Jiajie Peng, Qiang Deng, et al. · Molecular Therapy — Nucleic Acids (2026) | TGRS Research Map | TGRS